Long-term efficacy and tolerance of rituximab for post-transfusional alloimmune haemolytic anaemia in a thalassaemia patient

MeSH terms

• Adult
• Anemia, Hemolytic / drug therapy*
• Anemia, Hemolytic / etiology
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived
• Humans
• Immunologic Factors / adverse effects
• Immunologic Factors / therapeutic use*
• Male
• Rituximab
• Transfusion Reaction*
• beta-Thalassemia / complications*